b-lactamase enzymes responsible for bacterial resistance to antibiotics are among the most important health threats to the human population today. Understanding the increasingly vast structural motifs responsible for the catalytic mechanism of b-lactamases will help improve the future design of new generation antibiotics and mechanism-based inhibitors of these enzymes. Here we report the construction of a large murine single chain fragment variable (scFv) phage display library of size 2.7 9 10 9 with extended diversity by combining different mouse models. We have used two molecularly different inhibitors of the R-TEM b-lactamase as targets for selection of catalytic antibodies with b-lactamase activity. This novel methodology has led to the isolation of five antibody fragments, which are all capable of hydrolyzing the b-lactam ring. Structural modeling of the selected scFv has revealed the presence of different motifs in each of the antibody fragments potentially responsible for their catalytic activity. Our results confirm (a) the validity of using our two target inhibitors for the in vitro selection of catalytic antibodies endowed with b-lactamase activity, and (b) the plasticity of the b-lactamase active site responsible for the wide resistance of these enzymes to clinically available inhibitors and antibiotics.
Introduction b-lactamases are enzymes responsible for the resistance of bacteria to b-lactam antibiotics by hydrolyzing their conserved b-lactam moiety thus destroying their antibiotic activity. The many different commercially available antibiotic molecules with a b-lactam ring form stable complexes with penicillin-binding proteins (PBPs) in the membrane, inhibiting peptidoglycan biosynthesis and leading to bacterial cell death [1] . A major challenge of antibiotic design is, however, that despite the chemical modifications of penams and cephems to yield drugs with better affinity for PBPs and poorer substrates for b-lactamases, new bacteria continue to emerge capable of developing more effective b-lactamases adapted to the hydrolysis of newly designed antibiotics [2] . Such an evolutionary adaptability seems to be inevitable because nature takes care
Abbreviations DMSO, dimethyl sulfoxide; ELISA, enzyme-linked immunosorbent assay; ESBL, extended spectrum b-lactamase; PBS, phosphate-buffered saline; PCR, polymerase chain reaction; RT, reverse transcription; scFv, single chain fragment variable.
to tinker with the active sites of enzymes to fit emerging new substrates and thus acquire new catalytic functions [3] . In class A b-lactamases, numerous studies have determined the residues Ser 70 , Lys 73 , Ser 130 , and Glu 166 to play a major role in the catalytic mechanism [4] . The rapid evolution of bacteria as a result of exposure to a wider clinical spectrum of third-generation antibiotics has led to the generation of structurally different extended spectrum b-lactamases (ESBL) [5] . Interestingly, the mutations responsible for these evolved enzymes are generally near the substrate-binding site but do not directly contribute to catalysis. Studies have shown that these modifications effectively aid the enzyme resistance by expanding the active site cavity in order to either accommodate larger substrates or improve the formation of electrostatic bonds [6] [7] [8] .
Identifying the vast spectrum of structural motifs capable of holding this catalytic activity is therefore essential to understand the evolutionary capabilities of an enzyme [9] and an important step toward the future design of clinically useful antibiotics and b-lactamase inhibitors.
Phage display is a powerful technique for the study of protein-ligand interactions [10] [11] [12] [13] . The use of this technology for the display of a vast antibody repertoire, the robust screening or selection of a variety of target antigens, leading to the rapid recovery of specific antibody candidates is one of the most successful uses of this technique today. The construction of antibody libraries, however, is a delicate process involving many crucial steps, which may influence the size and diversity of the final result [14] . Care needs to be taken to ensure the coverage of a large antibody sequence diversity in order to (a) mimic the natural B-cell repertoire as close as possible and (b) increase chances of selecting candidates with desired properties. Recently, we have developed a new strategy for obtaining large phage display single chain fragment variable (scFv) libraries [15] . In order to further improve the library construction process and increase the diversity of represented immunoglobulin genes, we report here a newly designed set of oligonucleotide primers targeting the V regions of murine antibodies based on a novel and thorough analysis of the IMGT/LIGM-DB database [16] .
Catalytic antibodies capable of catalyzing a wide range of enzymatic reactions have been generated by the immunization of animals with chemically designed transition state analogs (TSA) as haptens [17] [18] [19] [20] [21] . Reactive immunization uses a chemically reactive molecule as a hapten in order to promote a chemical reactivity in the antibody-combining site during immunization [22] . This technique has proven most successful for the elicitation of catalytic antibodies so far, producing abzymes approaching the catalytic efficiencies of natural enzymes [23] . Mechanism-based inhibitors have proven to be promising candidates in the design of reactive immunogens due to their ability to covalently react with the active site in target proteins and inhibit their activity [24] . The innate reactivity of such molecules can be used to elicit highly evolved biocatalysts that conserve essential residues for covalent catalysis [25] . This strategy has previously been applied for the selection of catalytic antibodies endowed with b-lactamase activity, by using the structure of penam sulfones, suicide substrates of the enzyme b-lactamase [26, 27] , as target of selection [28] .
In the present study, we report the construction of a phage display scFv library of size 2.7 9 10 9 , from the classical murine strains Balb/C (healthy) and the SJL/J strain (susceptible to developing autoimmune disease), which has previously shown to express higher levels of catalytic antibodies [29, 30] . This library represents four different IgG immune repertoires: (a) healthy and nonimmunized, (b) healthy and immunized with KLHconjugated penam sulfone hapten, (c) autoimmune prone and nonimmunized, and (d) autoimmune prone and immunized. The repertoires are identifiable via a novel 'restriction bar-coding' technique, providing the first reported example of such methodology, in order to perform 2D screening. We have used two molecularly different inhibitors of the R-TEM b-lactamase enzyme as targets of selection: (a) a cyclic seven-residue peptidic inhibitor [31, 32] , and (b) the penam sulfone derivative used as the immunogen [33] . We have selected five antibody fragments having hydrolytic activity on a cephalosporin b-lactam ring with different structural motifs potentially attributed to their catalytic activity. Our results confirm the capability of the two b-lactamase inhibitor targets to efficiently promote the formation of catalytic antibodies endowed with this activity. Furthermore, they provide additional information on the potential structural possibilities capable of holding a b-lactamase catalytic function.
Results

Design of primers for the library construction
We have used isotype-specific primers to target only rearranged IgG RNA in the reverse transcription polymerase chain reaction (RT-PCR) reaction (Table S1) . We have applied a two-step PCR strategy for the amplification of immunoglobulin variable regions. In the first reaction step (PCR1), we target the leader sequences L-PART1 of immunoglobulins at the 5 0 end and the constant regions at the 3 0 end [34, 35] . In the
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The FEBS Journal 284 (2017) 634-653 ª 2017 Federation of European Biochemical Societies second nested reaction step (PCR2), we target sequences in FR1 at the 5 0 extremity and sequences in FR4 at the 3 0 extremity. We have designed novel sets of oligonucleotide primers for the two PCR reactions, based on a thorough analysis of the IMGT/LIGM-DB database [16] (Tables S2-S7 ). The primers designed for PCR2 have been inspired by a previous report [36] . The strategy of primer design is detailed in Materials and methods.
Construction of uniquely restriction bar-coded host vectors
For the cloning of immunoglobulin genes, we have used the phagemid vector pAK100 given to us by A. Plueckthun [37] . In order to pool the four libraries together and still be able to identify the library origin of any isolated clone, we have modified this phagemid to generate four slightly different but easily distinguishable vectors. For each altered vector (pAK101, pAK102, and pAK103), a single restriction site has been eliminated via a nucleotide deletion. The mutated restriction site for each vector and its attribution to one library is detailed in Table 1 . With this methodology, the size of the modified phagemids remains intact thus preventing any undesirable effect on the transformation step during library construction or on phage amplification. Such 'restriction bar-coding' of the phagemids offers the possibility of distinguishing between the four vectors by a number of simple restriction digestion steps.
If, however, there are any ambiguities in the obtained restriction profiles, i.e., due to the presence of the concerned restriction sites in the scFv sequence itself, sequencing will identify the library of origin.
Library size and diversity
The combined pool of the four libraries leads to the creation of a large repertoire of size 2.7 9 10 9 ( Table 2) . We have analyzed a population of 400 sequences from the pooled library (a window of 100 sequences per library) via conventional Sanger sequencing. The determination of the percentage of identity of all sequences determined by the CLUSTALW2 tool [38] has demonstrated that all the sequences are unique, confirming the diversity of our library (data not shown). Considering each immunoglobulin gene segment (IGKV, IGKJ, IGHV, IGHJ, and IGHD) separately, we have obtained and analyzed a total number of 1934 gene sequences. Within this population, we have found 10 pseudogenes (0.52%), which is in accord with findings of other teams [39] . The presence of pseudogenes in our library could be explained by the potential homology of some designed primers, despite the inclusion of only 'functional' genes to pseudogene sequences.
We have performed an analysis using the IMGT Ò / V-QUEST tool [40] for the determination of gene subgroups of the 400 sequenced scFv fragments. First, we note the presence of different gene subgroups demonstrating the high level of diversity of the libraries and validating the primer design (Fig. 1A,B) . The represented genes include 11 of the 19 IGKV subgroups, 4 of the 5 IGKJ subgroups, 7 of the 15 IGHV subgroups, and finally all the IGHD and IGHJ subgroups. Taken together, 32 of the 49 total gene subgroups referenced in IMGT Ò are represented in the 400 sequences analyzed (65.3%). Second, if we take into account the overall low representation of the 'rare' gene subgroups present in IMGT with frequencies of less than 1% (15 of 49), and the fact that we are focusing on a window of 100 sequences per library, we can expect the representation of only 34 gene subgroups. This means that 91.1% of the gene subgroups expected to be present in our small sample size is represented. The capability to represent this large percentage of the subgroups referenced in IMGT Ò indicates the high quality of our primer design. Despite the diversity of the four libraries, we have not observed any k gene subgroups in the pool of 400 analyzed sequences. We have therefore performed an experiment to ensure the capability of our primer set to amplify murine k genes. We have first used only the k Table 1 . Modified phagemids and corresponding eliminated restriction sites.
Phagemid
Eliminated restriction site Library attribution
For the libraries, (ni) corresponds to a nonimmunized library and (i) corresponds to an immunized one. primers of our primer mix, namely LPL1, LPL2, and IgL for PCR1, and OVL and VL3 0 C for PCR2, and performed PCR amplification on a previously prepared cDNA sample of immunized Balb/C mice. Results show that the isolated k primers are indeed capable of amplifying immunoglobulin k genes (data not shown).
Selection
In order to select for catalytic antibodies with b-lactamase activity, we have chosen two strategic targets:
A cyclic peptide, Pep90, which has been selected against the idiotope of 9G4H9, a catalytic antibody with b-lactamase activity. Pep90, therefore, is potentially the structural mirror image of the active site of the enzyme [31, 32] . As a result, antibodies selected against this peptide can potentially mimic the active site of the enzyme and be endowed with b-lactamase activity. A penam sulfone derivative [33, 41] , which has been used for the immunization of mice in order to deliberately induce the production of catalytic antibodies with b-lactamase activity. It is a suicide substrate of b-lactamase, and therefore, antibodies with affinity or reactivity toward this molecule can also potentially mimic the enzyme active site and be endowed with the same activity. The structure of this molecule is shown in Fig. 2 . Both targets are biotinylated and the support structure of the selection method consists of streptavidinconjugated magnetic beads. Several panning rounds are performed to enrich the pool of high-affinity binders. Finally, a sufficient number of the selected phages are screened in order to isolate positive clones, exhibiting affinity toward the target.
The selection against Pep90 has been performed by immobilizing 2 nmol of peptide per 1 mg of beads. We have performed seven panning cycles following a negative round, in order to eliminate the enriched phages specific to parts of the support structure other than the target. The enrichment results are shown in Fig. 3A . A phage-ELISA experiment has been performed after each selection cycle. Results demonstrate an increase after seven selection rounds (Fig. 3C ). We have screened 22 individual clones and have isolated three binders, namely P90C1, P90C2, and P90C3. The selection against the penam sulfone target has been performed by immobilizing 3.5 nmol of target molecule per 1 mg of beads. We have tried to use a reducing agent in the elution step to break the disulfide bond of the spacer arm of the penam sulfone, in order to release the captured phage-antibody. However, after three rounds of selection, eluted by 50 mM DTT, we did not observe any phage amplification. We then proceeded with following the same protocol of selection used in the first procedure against Pep90, with an elution step using a pH drop. We have performed six panning cycles for this second selection procedure. The enrichment results are shown in Fig. 3B and the phage-ELISA results in Fig. 3D . We have screened 30 individual clones and have isolated two binders, namely PSC1 and PSC2.
The sequences of the five selected antibody fragments along with the antibody 9G4H9 are shown in Fig. 4 . All residue numberings have been attributed sequentially (order of appearance in the sequence), similar to that used for 9G4H9 in the referenced publications [42, 43] . 9G4H9 is a catalytic antibody previously produced by our group via an anti-idiotypic strategy and is endowed with b-lactamase activity [42, 44] . We have determined that two of the selected clones from the Pep90 selection procedure, namely P90C1 and P90C2, originate from the immunized Balb/C library, whereas P90C3 and the two clones isolated from the penam sulfone selection, namely PSC1 and PSC2, originate from the nonimmunized SJL/J library. The library origin and gene subgroups of each of the five selected scFv are summarized in Table 3 .
The average sequence identity between the clones selected against Pep90 (P90C1, P90C2, and P90C3) determined by using the CLUSTALW identity matrix tool [38] is 82.52% AE 7.07. In the same manner, the identity between the clones selected against the penam sulfone target (PSC1 and PSC2) is 81.20% AE 6.81. Interestingly, the average sequence identity between the Pep90-selected clones versus the penam sulfoneselected clones is only 66.60% AE 1.45. This suggests that the target against which the selection has been performed has introduced a certain level of sequence similarity. It is also important to note the strong sequence similarity of the light chain CDR3 for P90C1 and P90C3, even though these antibody fragments originate from two different libraries (respectively the immunized Balb/C and the nonimmunized SJL/J libraries).
Catalytic activity
We have tested for the presence of b-lactamase activity with two substrates: (a) Nitrocefin ( ) that has been previously validated by site-directed mutagenesis [43] is highlighted by a red box. The corresponding homologous site in PSC1 deduced from its model structure is highlighted by a violet box. SxxK motifs typical of ß-lactamases are also highlighted. The motif is present only in the most active antibody fragments P90C2 and in 9G4H9. The dashes represent the gaps inserted in the alignment due to the GENEIOUS software. All residue numbering have been attributed sequentially (order of appearance in the sequence), similar to that used for 9G4H9 in the referenced publications and is therefore different from that used by IMGT. 0047692 A1, 02/19/2009), both cephalosporin substrates. Both of these tests are qualitative and are used for the detection of the presence of b-lactamase-like activity performed by the phagedisplayed scFv. Importantly, assessment of catalytic activity was performed with the scFv fragments displayed on the surface of phage, thus preventing us from quantitatively evaluating the catalytic parameters. The initial slope was thus used to compare the relative activity of scFv displayed on phage surface. It is important to note that such a measurement, on phage-displayed scFv, is indispensable for the validation of the selection strategy and has to be considered as a prerequisite to the soluble expression of the selected scFv fragments.
The results of the colorimetric assay using Nitrocefin demonstrate that three of the five selected antibody fragments are capable of hydrolyzing the substrate (Fig. 5C ). In the fluorometric assay using Fluorocillin TM , the penicillinase enzyme displays a Michaelis-Menten behavior with an initial slope of 19.7 min
À1
, whereas the negative controls, WT phage, as well as the spontaneous hydrolysis of Fluorocillin TM , do not. A control experiment has confirmed that the phage particles do not fluoresce in the absence of substrate. We have then tested the five selected antibody fragments along with 9G4H9, all expressed on the surface of phage. The initial slopes of the selected scFv and the controls are summarized in Table 4 . P90C2 demonstrates the highest activity with an initial slope of 29.4 min À1 . The most active scFv P90C2 has been cloned, expressed in soluble form (i.e., in the absence of phage), purified, and refolded. Its purity was controlled by SDS/PAGE and its molecular weight was about 27 000 Da as expected (data not shown). About 50 mg of purified scFv was obtained from 1 L of 
For the libraries, (ni) corresponds to a nonimmunized library and (i) corresponds to an immunized one. The signs À to +++ indicate the relative level of the measured property. PS, penam sulfone. culture. We have then tested its ability to hydrolyze Fluorocillin TM . The soluble P90C2 has not demonstrated a catalytic activity in the tested conditions. This assay has illustrated that all five selected antibodies display some activity using Fluorocillin TM as substrate when presented on phage surface. These results are in general coherent with the results of the qualitative colorimetric assay, with the exception that clones P90C1 and P90C3 show positive results only on Fluorocillin TM . The difference between initial slope values of 9G4H9 and both P90C1 and P90C3 is not significant. However, the fact that all the three catalysts are able to hydrolyze Fluorocillin TM but only 9G4H9 hydrolyzes also Nitrocefin, suggests that the specificity of P90C1 and P90C3 is potentially different from that of 9G4H9.
Structural modeling
From Fig. 4 , we observe that one of the selected catalytic antibody fragments, namely PSC1, displays the same residues in its amino acid sequence as those experimentally determined to be involved in the catalytic activity of 9G4H9 [43] (red box). Interestingly, the other antibody fragments do not share this similarity, at least at the amino-acid-sequence level. We have examined the selected antibodies at a threedimensional structural level via 3D modeling, using the ROSETTAANTIBODY software [46] . Based on the active site of the class A, C, and D b-lactamases (PDB 1BTL, 1GCE, and 1K54, respectively), we have manually searched for structural motifs that resemble the structural positioning of the corresponding active site residues. In brief, we checked the distance between every pair of serine residues that was compatible with those found in the class A, C, and D enzymes (i.e., in the range of 4.0-6.0 A between their Cß). For the remaining two residues, we have considered the availability of amino acids with similar positioning as well as similar physicochemical properties as the lysine and the catalytic base glutamate each within 6 A of the serine. For example, in place of the lysine residue, we have also considered potential arginine residues, whose role has been confirmed in the model antibody 9G4H9 [43] as well as in previous work on a different catalytic antibody [47] . Additionally, in place of a glutamate residue, we have also considered potential tyrosine residues, whose involvement in class C enzymes [48] or in a b-lactamase variant [49] has also been previously demonstrated and potential aspartate residues, whose physicochemical properties are similar.
A detailed account of our analysis is provided in Table 5 , where the residue numbering for each sequence is that shown in Fig. 4 . All the listed putative catalytic sites compared very well with the geometrical constraints observed between the two serine residues, the catalytic base (proton acceptor), and the general base (Lys or Arg) in class A, C, and D ß-lactamases. This is depicted for the most active P90C2 in Fig. 6 and for the other four antibody fragments in Figs 7-9. The proton acceptor is most of the time a glutamate or aspartate but a putative tyrosine was found in some instances like in P90C1, P90C2, and PSC2. Interestingly, multiple potential sites were found for all antibody fragments except for P90C1 and P90C3 which displayed only one potential site. Coincidentally, these two were the least active antibody fragments on Nitrocefin and Fluorocillin (see Fig. 5C and Table 4 ). PSC1 and PSC2 share a unique common structural motif involving the light chain residues S , and that was not found in the P90C series. Interestingly, R 24 in 9G4H9 was shown experimentally to be essential for the b-lactamase activity [43] . PSC2, P90C2, and 9G4H9 antibody fragments also feature a common motif involving S 7 and S 21 as catalytic serine residues, D/E 10 or Y 80 as catalytic base, and K 19 or K 23 as general base. The proposed active site residues of 9G4H9 are shown in Fig. 10 for comparison. It is also noteworthy that the most active antibody fragment, P90C2, harbors the typical SxxK motif (Fig. 4) of the family of ß-lactamases on its light chain and has been detected as a potential catalytic site based on the geometrical comparison with the known structures of ß-lactamases. Here the catalytic proton acceptor would be Y 91 located on the other chain (Fig. 6 ). This SxxK motif is also observed in 9G4H9 (Fig. 4) but on The reactions were performed in PBS buffer (pH 7.4) and were followed over 200 min. The substrate used is Fluorocillin TM . The ß-lactamase was used under soluble form at 45 nM. The negative control was the phage without any displayed scFv. For each experiment using scFv displayed on phage, and for the negative control, 5 9 10 13 phage particles were used. Note that the concentration of scFv clones is not measurable due to the heterogeneity of the number of scFv presented on the surface of each phage particle.
the heavy chain where the catalytic base is E
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( Fig. 10) . The SxxK motif has not been found in the other antibody fragments.
Discussion
In the past few decades, catalytic antibodies have become the focus of interest in studying a new aspect of the immune response: the tendency to induce the maturation of B lymphocytes capable of catalyzing a wide spectrum of enzymatic reactions. The diverse repertoire of the immune system can potentially be tapped to provide different structural supports for a given catalytic mechanism. The b-lactamase enzyme family, responsible for bacterial resistance to antibiotics, has a largely plastic active site, displaying different protein structures capable of maintaining this catalytic activity. This has been problematic for the development of effective antibiotic compounds. In the attempt of better understanding the structural plasticity of the b-lactamase active site, we have used the richly diverse source of an immune repertoire to isolate different structural motifs capable of catalyzing this reaction.
We have constructed four phage-displayed libraries representing immune repertoires with different genetic backgrounds and immunization states. The novel technique for the construction libraries described in this study has several advantages: (a) by using isotype-specific primers, we are able to reduce the pool of cDNA in one single reaction, increasing the specificity of the overall procedure, (b) by targeting the L-PART1 regions (having a lower diversity) in the first PCR reaction, we maintain the integrity of the 5 0 regions of immunoglobulin sequences (FR1), leading to a more accurate representation of the murine repertoires, (c) by avoiding the ligation step of a known oligonucleotide fragment (as required in RACE PCR) [50, 51] , we do not limit the diversity and size of our library to this ligation efficiency, thus increasing the size of the libraries, (d) by redesigning a more complete mix of degenerated primer sequences used for the amplification steps, we ensure the amplification of a higher number of immunoglobulin sequences, thus increasing the diversity of the libraries, and (e) by using a novel 'restriction barcoding' strategy of the host vectors, we are able to pool the four libraries together in order to create a final library of size 2.7 9 10 9 . The analysis of the total number of gene subgroups observed in the four libraries reported in this study indicates the good quality of the newly designed primers. Previously, we have constructed a naive SJL/J library by use of a different set of primers [15] , in Table 5 . Identification of putative catalytic sites in the studied antibody fragments that shared structural homology with active site residues of class A, C, and D b-lactamases. These were compared with the previously studied 9G4H9 antibody fragment. The predicted serine that was in principle closer to the catalytic base (proton acceptor) is indicated between parentheses. Residue numbering is according to sequential order in the sequence (Fig. 4) which we observed an overexpression of the gene subgroups IGKV2 and IGKV6 compared to the data available in IMGT Ò . We hypothesized at the time that this discrepancy was either due to a bias in the design of primers used or to the fact that the IMGT Ò sequences referenced in GeneFrequency [52] are based mostly on monoclonal antibodies induced by immunization and might not be an appropriate reference. Comparing these results with the data obtained for the naive SJL/J library reported here (constructed by the same technique but a different and newly designed set of primers), we observe differences in the two gene expression profiles. This indicates that the design strategy of primers has a crucial influence on the final representation of the immunoglobulin repertoire. Therefore, the broader is the range of immunoglobulin sequences covered by the primer mix, the more accurate is the representation of the produced libraries of the in vivo repertoire. Nevertheless, if we consider the murine immunoglobulin pool to be composed of a j : k ratio of 95 : 5 [53] , the absence of k genes in the pool of 400 sequences is questionable. We have, however, confirmed the absence of a bias in our primer mix and therefore suggest that the ratio of j to k genes in a murine immune repertoire might be higher than 95 : 5, as previously suggested by other groups [54] [55] [56] .
By combining the four immunological backgrounds, we have contributed to the increased diversity of the final library, making it an excellent reservoir for the Table 5 . Numbering is according to sequential order of residues and is identical to those in Fig. 4. selection of antibodies against targets of any potential interest. We have subsequently used two strategically designed targets in order to select for catalytic antibodies endowed with b-lactamase activity and to analyze the structural differences in their active sites. We have demonstrated that all five antibody fragments on phage surface display activity in the fluorometric assay, on the substrate Fluorocillin TM . Our group was the first to obtain catalytic antibodies displaying b-lactamase activity by the exploitation of the idiotypic network [42] . Using this strategy, we had screened more than several hundreds of clones to isolate an interesting candidate. With the current approach, using two distinct targets, we have successfully selected five catalytic clones displaying significant activity, illustrating the power of this selection system. The absence of such activity when scFv P90C2 is expressed in soluble form, suggests that the structure of this antibody is dependent on the experimental conditions, and possibly even on stabilization caused by the link with the PIII phage-protein. Table 5 . Numbering is according to sequential order of residues and is identical to those in Fig. 4 . Fig. 8 . Putative catalytic sites identified in PSC2 comparable to class A, C, and D blactamase active residues. The figure depicts each of these sites, (A-C), in detail and corresponds to those listed in Table 5 . Numbering is according to sequential order of residues and is identical to those in Fig. 4 . Table 5 . Numbering is according to sequential order of residues and is identical to those in Fig. 4 . Table 5 . Numbering is according to sequential order of residues and is identical to those in Fig. 4 .
Aside from differences in substrate specificities of selected clones, the fact that antibody fragments P90C1 and P90C3 do not show activity on Nitrocefin could also be due to a weaker sensitivity of the colorimetric assay.
An interesting point about the selection results is that the clones selected against the peptide Pep90, namely P90C1, P90C2, and P90C3, demonstrate a blactamase activity when displayed on phage surface. This gives Pep90 a great deal of importance, indicating the ability of this small peptide, which has been isolated via a selection procedure against the catalytic antibody 9G4H9 [31] to transfer important functional information between 9G4H9 and the newly selected antibodies. Remarkably, 9G4H9 and P90C2 share the typical SxxK motifs and molecular modeling showed that these residues were involved in a putative active site. Considering the relationship between b-lactamase, 9G4H9, Pep90, and P90C2 (the clone with the highest activity), this observation has important implications for the idiotypic network and the transfer of structural memory and catalytic function through protein/protein interactions. This type of cross-reactivity, here caused by a peptide, also exemplified by the cross-reactivity of antibodies with MBP and EBV illustrated by the group of Gabibov [57] , has implications for the importance of the role of such structures in different pathologies and their ability to induce the expression of catalytic antibodies. This transfer of functional information could for example explain why in certain disease states, such as MS, a high concentration of a self-molecule elicits the maturation of a catalytic antibody [58] .
Several structural analyses of catalytic antibodies have shown that they resemble their enzymatic counterparts by their three-dimensional structure [43, 59, 60] . Therefore, comparing the selected antibodies to the enzyme b-lactamase at a structural level could potentially elucidate some structure-function relationships. Interestingly, despite their different sequences, at least three structural motifs similar to the active site of blactamase were found for antibodies P90C2, PSC1, and PSC2, the only three antibodies demonstrating activity on Nitrocefin and demonstrating the three highest activities on Fluorocillin TM . Here, similar to previous reports, we have observed a higher divergence of enzyme sequence as compared to enzyme structure [3] . Only one site was found for P90C1 and P90C3. This potentially offers an explanation for their lower catalytic activity. The validity of these results and assumptions needs to be confirmed by further sitedirected mutagenesis and/or protein crystallography studies.
Together, these results demonstrate further the plasticity of the structures capable of catalyzing the b-lactam ring hydrolysis. The confirmation of the current results will provide valuable information on the different mechanisms involved in antibiotic resistance performed by different ESBL enzymes. These results, therefore, have potential value for the further design of novel antibiotic candidates. Finally, in a broader context, the prevalence of catalytic scFv on the surface of phages according to their originating library will bring new insights on the influence of the immune repertoire on the possibility to develop spontaneous catalytic antibodies.
Materials and methods
Mice and immunization
The protocol for animal work was performed according to the guidelines of the Charles Darwin ethical committee for animal experimentation (UPMC Paris) at the pathogen-free animal facility of the Cordeliers Research Center, Paris, France. Immunization of mice was performed by the society In-Cell-Art (Nantes, France). The antigen used was a biotinylated penam sulfone hapten conjugated to a KLH carrier (Alpha Chimica, Chatenay Malabry, France). The protocol used for the immunization was that detailed by Tawfik's group [30] . Briefly, Balb/C and SJL/J mice at 8 weeks of age were given a subcutaneous injection of 50 lg of the antigen formulated with Freund's complete adjuvant on day 0. A second dose of 50 lg of antigen formulated with Freund's incomplete adjuvant was given on day 17. Both immunized and naive mice were sacrificed by cervical dislocation on day 21 and the spleens were immediately removed.
Library construction cDNA synthesis
Total RNA was extracted from 30 mg of isolated and frozen mouse spleen tissue (~5 9 10 6 cells) using the NucleoSpin Ò RNA II kit (Cat. 740955; Machery-Nagel, Hoerdt, France) as per the manufacturer's protocol. The RNA purity and concentrations were determined by Experion TM RNA StdSens Analysis Kit (Cat. 7007103; Biorad, Marnes-La-Coquette, France). About 5 lg of RNA was reverse transcribed by the Phusion RT-PCR kit (Car. F5465; ThermoScientific, Waltham, MA, USA) using 10 pmol of a specific primer mix targeting segments in the constant region of the heavy chain, gamma (c), and light chains, kappa (j) and lambda (k) ( Table S1 ). The reaction mix and thermal cycling were followed as per the manufacturer's protocol.
Strategy of primer design
For the design of primers, we took into account an updated and thorough analysis of the murine immunoglobulin variable gene sequences listed in the IMGT/LIGM-DB database, consulted in June 2013 [14] . The system of annotation in the IMGT Ò database permits the selection of data according to different criteria such as species (but not the strains), isotypes, and functionality, set by the user. It also allows access to either germline or cDNA (sequences obtained from cloning of recombinant antibodies) immunoglobulin sequences. We chose to include all referenced germline sequences in order to avoid the exclusion of any potential genes that have not yet been cloned. We selected, however, only functional or productive sequences (open reading frame without stop codons and with normal splicing). Each of the immunoglobulin variable gene subgroups, IGKV (19 distinct subgroups), IGLV (2 distinct subgroups), and IGHV (15 distinct subgroups), was retrieved independently and the corresponding subsequences of L-PART1 were extracted. The sequences outputted by the database for each subgroup were then aligned and subdivided into clusters based on their percentage of identity (> 68%). A number of degenerate oligonucleotide primers were designed for each of these clusters based on the following criteria: (a) the length of the sequences is between 15 and 20 base pairs, (b) more than 50% of each sequence consists of GC base pairs, and (c) the level of degeneracy for each primer is less than 32%. In this manner, the ensemble of the designed oligonucleotide primers covers the entire population of the immunoglobulin sequences present in the IMGT-LIGM-DB database. In PCR1, for the amplification of IGHV genes, we designed 19 primers with a total degeneracy factor of 89; for IGKV, 30 primers with a total degeneracy factor of 240; and finally for IGLV, 2 primers with a degeneracy factor of 3. In PCR2, for the amplification of IGKV, we designed a total number of 35 primers with a total degeneracy factor of 460, a single IGLV with a degeneracy factor of 1, and 15 IGHV primers with a degeneracy factor of 56.
VL and VH amplification by nested PCR
Synthesized cDNA (5 lg) was used in a two-step PCR strategy for the amplification of variable light VL and variable heavy VH sequences. For the amplification of VL in the first PCR reaction (PCR1), 5 lL of cDNA was mixed with 200 lM of dNTP, 4.5 lM of MgSO 4 , 2 lM forward and 2 lM of back primers, 1 U of Vent Ò DNA polymerase (Cat.
M0254S; New England Biolabs, Ipswich, MA, USA), and 5 lL of 10X buffer in a 50 lL total reaction mix. The forward primers target regions in the signal sequence L-PART1 of light chains j and k sequences ( Table 2 ). The back primers target segments in the constant regions of these sequences, same as those used in RT-PCR (Table S1 : IgK and IgL). For the amplification of VH in PCR1, the similar parameters were used as above with only the MgSO 4 concentration decreased to 3.5 lM. The salt concentrations were optimized separately for each PCR reaction. The VH forward primers targeting the L-PART1 sequences of heavy chain c are listed in Table S3 and the back primers in Table 1 (IgG1, 2a, 2b, and 3 ). Both reactions were heated for 3 min at 95°C before performing 25 cycles (1 min at 95°C, 30 s at a temperature gradient from 68 to 58°C, 1 min at 75°C). At the end of the PCR, the reaction was heated at 75°C for 7 min. The temperature gradient for the annealing step was used due to the presence of a large number of different primers in each mix, in order to ensure the annealing of all to their corresponding sequences and favoring in priority the most specific ones. A second nested PCR reaction (PCR2) was followed using 1 lL of a 10 times diluted sample of the PCR1 results for VL and 1 lL of the undiluted PCR1 results for VH. The dilution of the VL PCR1 results was necessary prior to use in PCR2, due to the high concentration of amplified genes after PCR1. The composition of these two reactions was similar to PCR1 except for the salt concentrations: 6 lM MgSO 4 used for VL and 4.5 lM for VH amplification. The forward primers, targeting framework 1 (FR1), for the amplification of VL j and k and VH are listed in Tables S4 and S5 . The back primers targeting framework 4 (FR4) regions of IGVH, IGVK, and IGVL are those previously described [15] (Tables S5 and S7 ). The thermal cycling was the same as that in PCR1. The final PCR products of VL and VH were then run on a 1.5% agarose gel, cut out and purified by the QIAquick Gel Extraction Kit (Cat. 28704; Qiagen, Courtaboeuf, France) as per the manufacturer's protocol.
Assembly of scFv
The purified VL and VH (approximately 5 ngÁlL À1 ) were then assembled by single overlap extension polymerase chain reaction (SOE-PCR) in a 50 lL reaction volume using PWO Master mix (Cat. 03789403001; Roche Applied Sciences, Meylan, France), following a protocol similar to what we have previously reported [15] . Briefly, VL and VH were associated via the overlapping linker sequences, introduced by the PCR2 primers, in a first step without any additional primers. This step involved an initial heating at 94°C, followed by 10 cycles (45 s at 94°C, 45 s at 50°C, and 1 min at 72°C) and finished by heating at 72°C for 7 min. In the second step, 1 lM of primers scFor (5 0 GGA ATT CGG CCC CCG AG 3 0 ) and scBack (5 0 TTA TTA CTC GCG GCC CAG CCG GCC 3 0 ) were added to the products of the first reaction and heated for 3 min at 94°C, followed by 30 cycles (45 s at 94°C, 50 s at 61°C, 30 s at 58°C, and 1 min at 72°C), and a final heating step of 7 min at 72°C. The assembled scFv fragments were then purified by QIAquick PCR Purification Kit (Cat. 28104; Qiagen) as per the manufacturer's protocol.
Rolling circle amplification, cloning, and transformation
Rolling circle amplification (RCA) was performed following a protocol previously published [15] . Briefly, 300 ng of assembled scFv was ligated end to end by the T4 Ligase (Cat. M1804; Promega, Charbonni eres-les-Bains, France) in order to yield circularized scFv fragments. These fragments were then subjected to amplification by the Phi29 polymerase using the illustra TempliPhi amplification kit (Cat. 25640010; GE Healthcare, Aulnay-sous-Bois, France). Phagemid host vectors were subjected to a multidigestion step prior to the digestion of both phagemids and RCA-amplified scFv fragments by the SfiI restriction enzyme. The scFv fragments were finally ligated into their host vectors by the T4 DNA ligase and electroporated into 50 lL of freshly prepared electro-competent Escherichia coli TG1 bacteria. The transformation results were grown overnight on solid media at 37°C, then scraped off and stored in 10 mL of liquid media with 20% glycerol at À80°C.
Construction of host vectors
The host vector for the construction libraries was the phagemid pAK100 engineered by Krebber's team [37] . In order to have four uniquely bar-coded vectors, three different versions of the phagemid pAK100 were constructed by performing point mutations using the QuikChangeII XL SiteDirected Mutagenesis Kit (Cat. 200521; Agilent Technologies, Les Ulis, France), as per the manufacturer's protocol. For each modified vector, primers were designed in order to remove a single restriction site by a nucleotide deletion. For the phagemid pAK101, the restriction site KpnI was removed by using the primers KpnFor (5 0 GCT TTT ATC GGG GAC CGC TCA CTG CCC 3 0 ) and KpnBack (5 0 GCG GGC AGT GAG CGG TCC CCG ATA AAA GC 3 0 ). For the phagemid pAK102, the restriction site EcoRI was removed by using the primers EcoFor (5 0 CTT CTG CTC GAC TTC GGC CCC CGA GGC 3 0 ) and EcoBack (5 0 GCC TCG GGG GCC GAA GTC GAG CAG AAG 3 0 ). Finally, for the phagemid pAK103, the restriction site
BstEII was removed by using the primers BstFor (5 0 CGC GAT TTG CTG GTG CCC CAA TGC GAC C 3 0 ) and
Phage purification
Preparation of the amplification culture 
Phages precipitation
The amplification culture was centrifuged at 3300 g for 30 min. The supernatant was collected and 1/5 (v/v) of a poly(ethylene glycol) 8000 solution with 2.5 mM NaCl was added. The solution was thoroughly mixed and incubated at 4°C on ice for 1 h. The phages were then pelleted by a centrifugation at 10 800 g at 4°C for 30 min. The supernatant was discarded and the phages were resuspended in 40 mL of H 2 O. To precipitate the phages, 1/5 (v/v) of the poly(ethylene glycol) solution was once again added and the suspension was incubated on ice for 30 min. The phages were once again pelleted by centrifugation at 3300 g for 30 min and resuspended in 1-2 mL of H 2 O.
Sequence analysis
For each library, about 100 individual clones were randomly selected and separately subcultured in 3 mL of Luria-Bertani (LB) medium in the presence of 25 lgÁmL À1 chloramphenicol. After incubation overnight at 37°C under agitation, the phagemids were purified by the QIAprep Spin Miniprep Kit (Cat. 27106; Qiagen) as per the manufacturer's protocol. The purified plasmids were sent for sequencing to Eurofins MWG operon (Ebersbarg, Germany), using the same pAK100 primers listed above.
Bioinformatics
The immunoglobulin sequences were obtained from the IMGT Ò database (IMGT Ò , the international ImMunoGeneTics information system Ò http://www.imgt.org) [52] using the IMGT/LIGM-DB tool [16] . The determination of immunoglobulin gene subgroups was performed by the IMGT/V-QUEST online tool [40] . The alignment of the sequences retrieved from IMGT Ò was performed by the MULTALIN software [61] . The determination of the percentage of identity between sequences was performed by the CLUSTALW2 (EMBL-EBI) tool [38] .
Selection
The Pep90 target (Eurogentec, Li ege, Belgium) has a molecular weight of 2061.5 gÁmol À1 and the following Nterminal to C-terminal amino acid sequence (underlined): and is soluble in 100% dimethyl sulfoxide (DMSO). The selection procedure was performed on straptividinconjugated magnetic beads (Cat. S1420S; New England Biolabs). The beads (200 lg) were washed three times with phosphate-buffered saline (PBS; pH 7.4). The wash buffer supernatant was collected after each wash step by placing the beads in contact with a magnet. The determined quantity of each target sufficient for saturation of the beads was immobilized on the beads by incubation at room temperature (RT) for 2 h under rotation. The Pep90 peptide stock solution was at 1. 
Phage titration
TG1 bacteria were grown in LB medium until they reach OD (600 nm) of 0.5. Recovered phage after each selection round was diluted in H 2 O by a serial dilution of factors of 10. One-hundred microliters of each dilution was used to infect 900 lL of the bacterial culture. The infected cells were incubated at 37°C for 30 min. One-hundred microliters of each infected culture was plated on LB-25 lgÁmL
À1
chloramphenicol solid medium and incubated overnight at 37°C. The number of colonies was counted the following day to determine the quantity of infectious phage.
Phage-ELISA
Nunc TM 96-well immuno plates (Cat. 3455; Thermo Scientific) were coated with 100 lL anti-biotin antibody (Cat. MA5-11251; Thermo Scientific) at 2 lgÁmL À1 in carbonate buffer. The plate was incubated at 37°C for 2 h. The wells were washed three times with PBS-T. The wells were blocked with 200 lL of PBS-BSA 1% and incubated at 37°C for 2 h. One-hundred microliters of phages (5 9 10 12 particles) was incubated with 100 lL of 1 lM target for 2 h at 37°C under rotation. After washing the blocked plates three times with PBS-T, each phage suspension was added to the wells in duplicates. The plate was incubated at 4°C overnight. The wells were washed the following day 15 times with PBS-T. The secondary HRP-conjugated anti-pVIII M13 antibody (Cat. 27942101, GE Healthcare), 100 lL at 2 lgÁmL À1 in PBS, was added to the wells and incubated at 37°C for 2 h. The wells were washed three times with PBS-T. The revelation was performed by adding 100 lL of ABTS (Cat. 37615; Thermo Scientific) to each well and the plate was incubated for 10 min, and the optical density was finally read at 405 nm.
Cloning, expression, and purification of soluble scFv P90C2
The soluble (i.e., in the absence of phage) scFv P90C2 was entirely built by gene synthesis and then codon optimized for prokaryotic expression using the proprietary software GENEIUS of Eurofins Genomics. The scFv was subcloned at the NdeI-BamHI restriction sites of pET9c expression vector (ThermoFisher). This new vector encoding the scFv P90C2 was expressed according to the following procedure: Transformed E. coli BL21 (DE3) were grown in shaking culture (220 r.p.m., 37°C) in LB broth supplemented with 50 lgÁmL À1 kanamycin, to an OD of 0.6 at 600 nm. Protein expression was induced by addition of 1 mM isopropyl b-D-1-thiogalactopyranoside (IPTG) and incubated for 3 h (220 r.p.m., 30°C). Induced cells were harvested by centrifugation at 4000 g for 10 min at 4°C and resuspended in Tris/HCl buffer (0.1 M, pH 8) containing the protease inhibitor (Pefabloc (R) SC). The solution was sonicated and centrifuged at 14 000 g for 10 min at 4°C. The supernatant was discarded, the pellet was solubilized in buffer A (8 M urea, 20 mM imidazole, 0.1 M Tris/HCl pH 8), and incubated for 1 h (230 r.p.m., 37°C). The lysate was sonicated (1 min, 16 W) and cleared by centrifugation at 14 000 g for 30 min at 4°C, and the supernatant was filtered on a 0.45 lm filter. The scFv fragment was purified by immobilized metal affinity chromatography in a 1 mL HisTrap HP column (GE Healthcare) using AKTA purifier, loaded and washed with buffer A at 0.5 mLÁmin
À1
, and eluted using buffer B: 8 M urea, 200 mM imidazole, 0.1 M Tris/HCl pH 8 at 0.5 mLÁmin
. Pooled elution fractions were fractionated by size exclusion chromatography in buffer B without imidazole. Fractions of the monomeric form of scFv were pooled and the final concentration (as measured by bicinchoninic acid, BCA, assay) was adjusted to 15 lM. The purity and molecular weight were assessed by SDS/ PAGE.
Refolding of the soluble scFv P90C2
The renaturation protocol was adapted from procedures previously described [62, 63] . Briefly, the scFv concentration was adjusted to 10 lM in 8 M urea, 0.1 M Tris/HCl pH 8 buffer. Urea was removed by dialysis with stepwise reduction of the denaturant concentration to 4 M (for 48 h), 2 M, 1 M, 0.5 M, and 0 (for 12-24 h at each concentration), using Slide-A-Lyzer MINI dialysis devices (MWCO 3500 Da; ThermoScientific). L-arginine (0.4 M) was added to the buffers throughout the stepwise dialysis to prevent protein aggregation. The oxidized and reduced forms of glutathione (0.75 and 7.5 mM, respectively) were added in the final steps of the dialysis (against 1 and 0.5 M Urea).
Colorimetric assay
Remel Nitrocefin disks from the company Oxoid (Cat. R211667, Dardilly, France) were brought to RT. Forty microliters of each phage sample (~5 9 10 13 phage particlesÁmL À1 ) and a similar volume of the penicillinase enzyme (45 nM) as positive control were deposited on disks and incubated for 1 h.
Fluorometric assay
Kinetic measurements were performed similar to a previous publication [64] . Briefly, the reaction was followed in 0.5 mL quartz cuvettes at RT in PBS (pH 7.4)-0.1% BSA, using a Varian Cary Eclipse Fluorescence Spectrophotometer with excitation at 495 nm and emission at 525 nm. The fluorescence was followed up for 200 nm. Most of the measurements were performed using the scFv presented on phage surface (~5 9 10 13 phage particlesÁmL À1 ). Concerning the scFv P90C2, kinetic parameters were determined using 7 lM of soluble and purified scFv and 0.5 lM of fluorocillin, according to Ben Naya et al. [64] .
Molecular modeling of scFv
The 3D modeling of selected scFv (here P90C1, P90C2, P90C3, PSC1, and PSC2) was performed according to the following procedure: The DNA sequences of their VL and VH chains were converted into amino acid sequences using the TRANSEQ package from EMBOSS [65] . These sequences were provided as input to the ROSETTAANTIBODY [46] module from the ROSETTA 3.0 package [66] , which was used to construct atomic models of the scFv. In the Rosetta protocol, both constant, FR and CDR regions are modeled. Rosetta separately builds homology models of VL and VH chains after identification of appropriate structural templates from PDB. The program then performs a docking of the two chains onto each other and the subsequent heterodimeric structure is further subjected to conformational optimization (side chain positioning, loop conformation, and VH-VL orientation). A total of five models per scFv were produced. Putative catalytic sites that possess two serines in the immediate vicinity of a lysine and glutamate or equivalent physicochemical groups were searched manually using PYMOL [67] . These were further confirmed by aligning them with the equivalent catalytic residues of b-lactamase (PDB: 1BTL) using the structural alignment tool in PYMOL.
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